Details for Patent: 9,155,699
✉ Email this page to a colleague
Summary for Patent: 9,155,699
| Title: | Pulmonary delivery for levodopa |
| Abstract: | In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung. |
| Inventor(s): | Jackson; Blair C. (South Grafton, MA), Bennett; David J. (Brighton, MA), Bartus; Raymond T. (San Diego, CA), Emerich; Dwaine F. (Glocester, RI) |
| Assignee: | Civitas Therapeutics, Inc. (Chelsea, MA) |
| Application Number: | 14/055,959 |
|
Patent Claim Types: see list of patent claims | Composition; Delivery; |
Drugs Protected by US Patent 9,155,699
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,155,699
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2003218307 | ⤷ Sign Up | |||
| Canada | 2478980 | ⤷ Sign Up | |||
| Cyprus | 1118517 | ⤷ Sign Up | |||
| Denmark | 1531798 | ⤷ Sign Up | |||
| Denmark | 2630954 | ⤷ Sign Up | |||
| European Patent Office | 1531798 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
